Fig. 1From: Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathwaysTumor growth curves of the 9 PDX models at the third generation. The models were established subcutaneously and median tumor volumes in 5 tumor-bearing mice from each model are representedBack to article page